Trial Profile
Clinical Trials Insight: 700013054
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 17 May 2006
Price :
$35
*
At a glance
- Drugs HE 2100 (Primary)
- Indications Nosocomial infections
- Focus Adverse reactions
- Sponsors Harbor Therapeutics
- 17 May 2006 New trial record.